|
5-Bromo-2′-deoxyuridine?? 5-溴-2′-脫氧尿苷 Synonym?: BUdR | 5-Bromo-1-(2-deoxy-β-D-ribofuranosyl)uracil | 5-BrdU | 5-溴-2′-脫氧尿苷 ?? | 5-Bromouracil deoxyriboside | 5-溴脫氧尿嘧啶核苷 | 5-溴, Descriptions: ?? Brdu,中文全名5-溴脫氧尿嘧啶核苷,為胸腺嘧啶的衍生物,可代替胸腺嘧啶在DNA合成期(S期),活體注射或細(xì)胞培養(yǎng)加入,而后利用抗Brdu單克隆抗體,ICC染色,顯示增殖細(xì)胞。同時(shí)結(jié)合其它細(xì)胞標(biāo)記物,雙重染色,可判斷增殖細(xì)胞的種類,增殖速度,對(duì)研究細(xì)胞動(dòng)力學(xué)有重要意義。 ??目前常用的細(xì)胞增殖標(biāo)記物有4種,Brdu (5-bromo-2--deoxyuridine), DNA polymerase α,PCNA (Proliferating cell nuclear antigen),Ki-67 等。因組織細(xì)胞內(nèi)無內(nèi)源性Brdu存在,所以Brdu應(yīng)用較廣。Brdu,中文全名5-溴脫氧尿嘧啶核苷,為胸腺嘧啶的衍生物,可代替胸腺嘧啶在DNA合成期(S期),活體注射或細(xì)胞培養(yǎng)加入,而后利用抗Brdu單克隆抗體,ICC染色,顯示增殖細(xì)胞。同時(shí)結(jié)合其它細(xì)胞標(biāo)記物,雙重染色,可判斷增殖細(xì)胞的種類,增殖速度,對(duì)研究細(xì)胞動(dòng)力學(xué)有重要意義。 APPLICATIONS: BrdU is selectively incorporated into cell DNA at the S phase of cell cycle. The use of BrdU as a thymidine analog has made possible the identification of DNA synthesis in suspensions of cells, cell smears and tissue sections. The incorporation of BrdU into DNA in place of thymidine is discussed by A.L. Givan.5 BrdU at 0.16 to 500 mg/mL of cell culture media produced inhibition of growth of KD cells (rabbit kidney cells). Effective inhibition at concentrations greater than 1.0 mg/mL was observed.6 It is incorporated, in vivo,by injecting 10-100 mg/kg at 10 mg/mL in saline intraperitoneally.7 It is also incorporated into bone marrow cells in culture at a final concentration of 10 mM at 37EC for one hour. For incorporation to occur, the BrdU must be phosphorylated in the cell by thymidine kinase.8 FITC-conjugated second antibodies can be used with antibodies specific for BrdU (Sigma product B2531) which will make "new" DNA fluoresce green; denatured DNA can be stained with propidium iodide and will fluoresce red. 技術(shù)參數(shù): Product Name?? 5-Bromo-2′-deoxyuridine,≥99% (HPLC) Product Number:B5002 Product Brand:Sigma CAS Number:59-14-3 Molecular Formula:C9H11BrN2O5 Molecular Weight:307.10 ???? ? Storage Temp: APPEARANCE:WHITE TO OFF-WHITE POWDER SOLUBILITY:CLEAR COLORLESS TO VERY FAINT YELLOW SOLUTION AT 50MG/ML OF 1MAMMONIUM HYDROXIDE UV-VIS SPECTRUM:EMM = 8.9 TO 9.2 AT LAMBDA MAX279 TO 280NM AT PH1.0 PURITY BY HPLC:99% MINIMUM SOLUBILITY / SOLUTION STABILITY: Sigma routinely tests the solubility at 50 mg/mL in Ordering Information
|
BRDU 5-溴-2′-脫氧尿苷 5-Bromo-2′-deoxyuridine
作者:翌圣生物科技(上海)股份有限公司 2010-02-18T00:00 (訪問量:8183)
翌圣生物科技(上海)股份有限公司 商家主頁
地 址: 上海市浦東新區(qū)天雄路166弄一號(hào)樓三層南單元
聯(lián)系人: 李自轉(zhuǎn)
電 話: 400-6111-883、021-34615995-8075
傳 真: 021-34615995-188
Email:lizizhuan@yeasen.com
相關(guān)咨詢
賦能CGT產(chǎn)業(yè)化 | 翌圣生物攜mRNA/AAV核心原料亮相ASGCT 2026波士頓 (2026-05-09T00:00 瀏覽數(shù):7140)
500+ 深度咨詢見證專業(yè)價(jià)值!翌圣生物 BIO KOREA 2026 圓滿收官 (2026-04-30T00:00 瀏覽數(shù):13393)
艾斯基因與翌圣生物達(dá)成戰(zhàn)略合作,攜手共拓表觀多組學(xué)新格局 (2026-04-27T00:00 瀏覽數(shù):12665)
Nature:胡新央/徐洋團(tuán)隊(duì)開發(fā)工程化免疫抑制樹突狀細(xì)胞防治心臟重塑 (2026-04-27T00:00 瀏覽數(shù):13144)
AACR 2026 | 圣地亞哥現(xiàn)場紀(jì)實(shí):在學(xué)術(shù)潮汐中,尋找腫瘤研究的精準(zhǔn)錨點(diǎn) (2026-04-24T00:00 瀏覽數(shù):13976)
赴首爾之約!翌圣生物與您相聚 BIO KOREA 2026 (2026-04-24T00:00 瀏覽數(shù):12600)
翌圣ELISA產(chǎn)品助力腫瘤免疫治療新突破:導(dǎo)電納米酶誘導(dǎo)原位腫瘤疫苗” (2026-04-24T00:00 瀏覽數(shù):10894)
《Nature》重磅:堿基編輯療法臨床治療β-地中海貧血,翌圣生物GMP級(jí)原料助力基因治療新突破 (2026-04-24T00:00 瀏覽數(shù):13630)
技術(shù)協(xié)同到生態(tài)共建,翌圣生物榮獲華大基因“最佳合作伙伴 (2026-04-24T00:00 瀏覽數(shù):13084)
翌圣生物實(shí)力出圈!聚勢廈門CACLP,共話 IVD 新勢能 (2026-03-27T00:00 瀏覽數(shù):17893)
